Vincent B.
- Country
- France
- Department
- Radiation Oncology
Research Overview
- NEoadjuvant chemoradiotherapy for Esophageal squamous cell carcinoma versus Definitive chemoradiotherapy with salvage Surgery as needed (The NEEDS Trial)
- Efficacy of ONC201 and Everolimus with Radiotherapy in Newly Diagnosed Diffuse Midline Gliomas H3K28M Mutant or EZHIP Positive Patients
- NACRE 2_Randomized phase III study evaluating two treatment strategies for locally advanced rectal cancer in patients ≥75 years old
Data & Insights
Has run more than one trial at 19 of 96 partner sites.
Specializations
Neuro-Oncology
Specializes in the treatment of diffuse intrinsic pontine glioma (DIPG) and diffuse midline gliomas. Investigates novel therapeutic approaches for glioblastoma patients using innovative treatment combinations including radiotherapy protocols.
- Brain Radionecrosis Management
- Advanced Glioma Treatment
- Pediatric Brain Tumors
Focuses on developing targeted therapies for both adult and pediatric brain malignancies.
Metastatic Disease
Conducts research in the treatment of brain metastases and vertebral metastases, exploring combined therapeutic approaches including stereotactic radiotherapy and targeted biological agents.
- Bone Metastasis Treatment
- Advanced Radiotherapy Techniques
- Therapeutic Combinations
Specializes in developing integrated treatment strategies for metastatic disease management.
Gastrointestinal Oncology
Expertise in treating esophageal squamous cell carcinoma, investigating various therapeutic approaches including neoadjuvant chemoradiotherapy and definitive chemoradiotherapy with surgical interventions.
- Esophageal Cancer Treatment
- Combined Modality Therapy
- Surgical Oncology
Focuses on optimizing treatment sequences for locally advanced esophageal cancer.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.